If you begin using Dupixent (dupilumab) and it works well for your condition, there’s no set time at which you would stop the medication. In most cases, you’ll stay on Dupixent long term, or as long ...

The first known lawsuit has now been filed against the makers of Dupixent (dupilumab), alleging that the popular eczema and asthma drug caused or accelerated a deadly form of lymphoma. Filed in ...

Common side effects of Dupixent for atopic dermatitis (eczema) include injection site reactions like pain or swelling, eye-related side effects such as pink eye or dry eyes, and increased risk of cold ...

Dupixent interacts with some medications like seizure drugs (phenytoin, carbamazepine), warfarin, and certain heart medications, potentially increasing side effects or reducing their effectiveness.

Common side effects of Dupixent include injection site reactions and mouth or throat pain. Serious side effects can include severe eye problems and certain conditions involving white blood cells, ...

Most people with asthma are able to control their symptoms by using inhaled medicines each day. But for some people with severe asthma, inhaled medicines are not enough to keep symptoms under control.

After hitting a home run with trial results for Dupixent in chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron are circling the bases, considering an exciting future with another ...

When you start a medication like Dupixent (dupilumab), you expect relief from eczema or asthma, not the devastation of a cancer diagnosis. Yet growing medical evidence shows that some patients ...

Dupixent drives a larger share of Sanofi's revenue, with atopic dermatitis (65%), asthma (20%), and CRSwNP (10%) as core indications; each faces varying competitive pressures. Revenue projections for ...

Five years after its first FDA approval in eczema, Sanofi’s Dupixent is still blazing a trail in inflammatory diseases. That’s the evaluation of Bill Sibold, Sanofi’s global head of specialty care, ...

Most people with a condition known as chronic rhinosinusitis with nasal polyps (CRSwNP) are able to control their symptoms by using medicines that are sprayed into the nose or taken by mouth. But some ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...